Providence Capital Advisors, LLC Becton Dickinson & CO Transaction History

Providence Capital Advisors, LLC

$487 Million
Q3 2024

A detailed history of Providence Capital Advisors, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Providence Capital Advisors, LLC holds 18,740 shares of BDX stock, worth $4.2 Million. This represents 0.93% of its overall portfolio holdings.

Number of Shares

18,740

Previous 18,524 1.17%

Holding current value

$4.2 Million

Previous $4.33 Million 4.37%

% of portfolio

0.93%

Previous 0.97%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$221.47 - $242.41 $47,837 - $52,360	216 Added 1.17%	18,740 $4.52 Million
Q2 2024 Aug 14, 2024	BUY	$225.07 - $246.17 $32,860 - $35,940	146 Added 0.79%	18,524 $4.33 Million
Q1 2024 May 13, 2024	BUY	$233.45 - $247.73 $70,035 - $74,319	300 Added 1.66%	18,378 $4.55 Million
Q3 2023 Nov 13, 2023	SELL	$254.9 - $283.59 $36,450 - $40,553	-143 Reduced 0.78%	18,078 $4.67 Million
Q2 2023 Aug 10, 2023	BUY	$238.39 - $265.32 $17,640 - $19,633	74 Added 0.41%	18,221 $4.81 Million
Q1 2023 May 17, 2023	BUY	$229.71 - $259.35 $1.03 Billion - $1.16 Billion	4,485,121 Added 63215.24%	4,492,216 $1.11 Billion
Q1 2023 May 17, 2023	SELL	$229.71 - $259.35 $1.03 Billion - $1.16 Billion	-4,474,069 Reduced 99.6%	18,147 $4.49 Million
Q1 2023 May 10, 2023	SELL	$229.71 - $259.35 $2.45 Million - $2.77 Million	-10,671 Reduced 60.06%	7,095 $1.76 Million
Q4 2022 Feb 07, 2023	BUY	$218.29 - $256.91 $28,159 - $33,141	129 Added 0.73%	17,766 $4.52 Million
Q3 2022 Nov 09, 2022	BUY	$51.03 - $264.23 $19,238 - $99,614	377 Added 2.18%	17,637 $3.93 Million
Q2 2022 Aug 09, 2022	BUY	$234.74 - $275.42 $150,468 - $176,544	641 Added 3.86%	17,260 $4.26 Million
Q1 2022 May 12, 2022	BUY	$243.64 - $270.48 $229,508 - $254,792	942 Added 6.01%	16,619 $4.31 Million
Q4 2021 Feb 11, 2022	BUY	$230.08 - $250.94 $143,800 - $156,837	625 Added 4.15%	15,677 $3.94 Million
Q3 2021 Nov 09, 2021	BUY	$232.72 - $256.47 $172,445 - $190,044	741 Added 5.18%	15,052 $3.7 Million
Q2 2021 Aug 09, 2021	BUY	$232.65 - $254.58 $84,219 - $92,157	362 Added 2.6%	14,311 $3.48 Million
Q1 2021 May 13, 2021	BUY	$232.09 - $256.88 $120,222 - $133,063	518 Added 3.86%	13,949 $3.39 Million
Q4 2020 Feb 11, 2021	BUY	$221.92 - $245.94 $290,271 - $321,689	1,308 Added 10.79%	13,431 $3.36 Million
Q3 2020 Nov 13, 2020	SELL	$215.77 - $276.76 $31,933 - $40,960	-148 Reduced 1.21%	12,123 $2.82 Million
Q2 2020 Aug 04, 2020	SELL	$219.9 - $263.41 $39,362 - $47,150	-179 Reduced 1.44%	12,271 $2.94 Million
Q1 2020 May 12, 2020	BUY	$195.69 - $279.01 $239,524 - $341,508	1,224 Added 10.9%	12,450 $2.86 Million
Q4 2019 Feb 13, 2020	BUY	$236.45 - $266.82 $29,556 - $33,352	125 Added 1.13%	11,226 $3.05 Million
Q3 2019 Nov 13, 2019	BUY	$230.58 - $256.08 $63,409 - $70,422	275 Added 2.54%	11,101 $2.81 Million
Q2 2019 Aug 13, 2019	BUY	$217.4 - $246.08 $41,306 - $46,755	190 Added 1.79%	10,826 $2.73 Million
Q1 2019 May 08, 2019	BUY	$206.05 - $248.17 $81,595 - $98,275	396 Added 3.87%	10,636 $2.66 Million
Q4 2018 Feb 01, 2019	BUY	$204.73 - $257.93 $9,827 - $12,380	48 Added 0.47%	10,240 $2.31 Million
Q3 2018 Nov 08, 2018	BUY	$233.07 - $256.0 $96,490 - $105,984	414 Added 4.23%	10,192 $2.66 Million
Q2 2018 Aug 08, 2018	BUY	$208.1 - $233.85 $81,367 - $91,435	391 Added 4.17%	9,778 $2.34 Million
Q1 2018 May 10, 2018	BUY	$205.46 - $240.27 $81,362 - $95,146	396 Added 4.4%	9,387 $2.03 Million
Q4 2017 Feb 12, 2018	BUY	$189.0 - $222.64 $1.7 Million - $2 Million	8,991	8,991 $1.93 Million

Others Institutions Holding BDX

# of Institutions

1,737

Shares Held

250M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Providence Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Providence Capital Advisors, LLC with notifications on news.

Account

Providence Capital Advisors, LLC Becton Dickinson & CO Transaction History